Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Odds Ratios can be misleading; it's better to also present risk and Relative Risks for clarity.

Serenoa repens is not proven effective for hair loss and may delay prostate cancer detection.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Finasteride increases CD8+ T cells in BPH tissues.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Androgen increases VEGF expression but not VEGFR-2 in rat corpus cavernous.

ALRV5XR effectively increases hair density in men with androgenetic alopecia without adverse effects.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

MK-386 reduces sebum DHT levels.

Serenoa repens is mostly safe but has some risks, especially at high doses or when used with other products for over two weeks.

Testosterone reduces knee movement, while flutamide and finasteride increase it.